☰

Artur Wnorowski, Ph.D. - Publications

Affiliations: 
2011- Department of Biopharmacy Medical University of Lublin 
 2012-2014 Laboratory of Clinical Investigation National Institute on Aging Intramural Research Program, Bethesda, MD, United States 
Area:
pharmacology, cell signaling, adrenergic receptors, cancer
Website:
https://www.zdrowiemolekularne.pl/
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pachòn Angona I, Daniel S, Martin H, Bonet A, Wnorowski A, Maj M, Jóźwiak K, Silva TB, Refouvelet B, Borges F, Marco-Contelles J, Ismaili L. Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels. Molecules (Basel, Switzerland). 25. PMID 32183349 DOI: 10.3390/Molecules25061329  0.693
2020 Zakrocka I, Targowska-Duda K, Wnorowski A, Kocki T, Jóźwiak K, Turski W, Załuska W. P0016Effect Of Gemfibrozil On Kynurenine Aminotransferase Activity And Kynurenic Acid Production In Rat Kidney Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P0016  0.66
2019 Walczak K, Wnorowski A, Turski WA, Plech T. Kynurenic Acid and Cancer: Facts and Controversies Cell Mol Life Sci. PMID 31659416 DOI: 10.1007/S00018-019-03332-W  0.316
2019 Malek R, Maj M, Wnorowski A, Jóźwiak K, Martin H, Iriepa I, Moraleda I, Chabchoub F, Marco-Contelles J, Ismaili L. Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy. Bioorganic Chemistry. 91: 103205. PMID 31446330 DOI: 10.1016/J.Bioorg.2019.103205  0.681
2019 Matysik-Woźniak A, Wnorowski A, Turski WA, Jóźwiak K, Jünemann A, Rejdak R. The presence and distribution of G protein-coupled receptor 35 (GPR35) in the human cornea - Evidences from in silico gene expression analysis and immunodetection. Experimental Eye Research. 179: 188-192. PMID 30445046 DOI: 10.1016/J.Exer.2018.11.011  0.699
2019 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro. Neurotoxicity Research. 35: 244-254. PMID 30178287 DOI: 10.1007/S12640-018-9952-9  0.761
2019 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Załuska W, Turski WA. FP026DICLOFENAC INHIBITS KYNURENINE AMINOTRANSFERASE ACTIVITY AND KYNURENIC ACID PRODUCTION IN RAT KIDNEY Nephrology Dialysis Transplantation. 34. DOI: 10.1093/Ndt/Gfz106.Fp026  0.669
2018 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 30370429 DOI: 10.1007/S00210-018-1572-7  0.76
2018 Chioua M, Buzzi E, Moraleda I, Iriepa I, Maj M, Wnorowski A, Giovannini C, Tramarin A, Portali F, Ismaili L, López-Alvarado P, Bolognesi ML, Jóźwiak K, Menéndez JC, Marco-Contelles J, et al. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease. European Journal of Medicinal Chemistry. 155: 839-846. PMID 29958119 DOI: 10.1016/J.Ejmech.2018.06.044  0.704
2018 Podgórska M, Ołdak M, Marthaler A, Fingerle A, Walch-Rückheim B, Lohse S, Müller CSL, Vogt T, Ustav M, Wnorowski A, Malejczyk M, Majewski S, Smola S. Chronic Inflammatory Microenvironment in Epidermodysplasia Verruciformis Skin Lesions: Role of the Synergism Between HPV8 E2 and C/EBPβ to Induce Pro-Inflammatory S100A8/A9 Proteins. Frontiers in Microbiology. 9: 392. PMID 29563902 DOI: 10.3389/Fmicb.2018.00392  0.709
2018 Zakrocka I, Targowska-Duda K, Wnorowski A, Kocki T, Jóźwiak K, Turski W. FP036THE INFLUENCE OF CANDESARTAN ON KYNURENIC ACID PRODUCTION IN RAT KIDNEY IN VITRO Nephrology Dialysis Transplantation. 33: i59-i59. DOI: 10.1093/Ndt/Gfy104.Fp036  0.653
2017 Plazinska A, Plazinski W, Luchowski R, Wnorowski A, Grudzinski W, Gruszecki WI. Ligand-induced action of the W286 rotamer toggle switch in the β-adrenergic receptor. Physical Chemistry Chemical Physics : Pccp. 20: 581-594. PMID 29226293 DOI: 10.1039/C7Cp04808D  0.689
2017 Bernier M, Catazaro J, Singh NS, Wnorowski A, Boguszewska-Czubara A, Jozwiak K, Powers R, Wainer IW. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts. International Journal of Cancer. PMID 28741686 DOI: 10.1002/Ijc.30904  0.774
2017 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA. Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications. Neurotoxicity Research. PMID 28733707 DOI: 10.1007/S12640-017-9781-2  0.759
2017 Wnorowski A, Such J, Paul RK, Wersto RP, Indig FE, Jozwiak K, Bernier M, Wainer IW. Concurrent Activation of β2-adrenergic Receptor and Blockage of GPR55 Disrupts Pro-Oncogenic Signaling in Glioma Cells Cell Signal. 36: 176-188. PMID 28495590 DOI: https://doi.org/10.1016/j.cellsig.2017.05.006  0.311
2017 Wnorowski A, Such J, Paul RK, Wersto RP, Indig FE, Jozwiak K, Bernier M, Wainer IW. Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells. Cellular Signalling. PMID 28495590 DOI: 10.1016/J.Cellsig.2017.05.006  0.78
2017 Żarnowski T, Tulidowicz-Bielak M, Żarnowska I, Mitosek-Szewczyk K, Wnorowski A, Jóźwiak K, Gasior M, Turski WA. Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye. Current Medicinal Chemistry. PMID 28486923 DOI: 10.2174/0929867324666170509120257  0.712
2016 Targowska-Duda KM, Wnorowski A, Budzynska B, Jozwiak K, Biala G, Arias HR. The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice. Behavioural Brain Research. PMID 26778787 DOI: 10.1016/J.Bbr.2016.01.002  0.746
2015 Wnorowski A, Sadowska M, Paul RK, Singh NS, Boguszewska-Czubara A, Jimenez L, Abdelmohsen K, Toll L, Jozwiak K, Bernier M, Wainer IW. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells. Cellular Signalling. 27: 997-1007. PMID 25703025 DOI: 10.1016/J.Cellsig.2015.02.012  0.779
2014 Wnorowski A, Jozwiak K. Homo- and hetero-oligomerization of β2-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology. Cellular Signalling. 26: 2259-65. PMID 25049076 DOI: 10.1016/J.Cellsig.2014.06.016  0.72
2014 Paul RK, Wnorowski A, Gonzalez-Mariscal I, Nayak SK, Pajak K, Moaddel R, Indig FE, Bernier M, Wainer IW. (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility. Biochemical Pharmacology. 87: 547-61. PMID 24355564 DOI: 10.1016/J.Bcp.2013.11.020  0.752
2014 Jozwiak K, Wnorowski A. Biological Mosaics–Oligomerization of G Protein-Coupled Receptors Biochemical Pharmacology. 3. DOI: 10.4172/2167-0501.1000E154  0.695
2014 Paul RK, Wnorowski A, Bernier M, Wainer IW. Abstract 4535: Inhibition of cell proliferation by (R,R')-4′-methoxy-1-naphthylfenoterol in breast cancer cell lines Cancer Research. 74: 4535-4535. DOI: 10.1158/1538-7445.Am2014-4535  0.673
2014 Wnorowski A, Paul RK, Jimenez L, Toll L, Kotb A, Bernier M, Wainer IW. Abstract 3680: (R,R')-4′-methoxy-1-naphtylfenoterol inhibits pro-survival signaling, proliferation and motility of select human melanoma cell lines Cancer Research. 74: 3680-3680. DOI: 10.1158/1538-7445.Am2014-3680  0.681
2013 Bernier M, Paul RK, Dossou KS, Wnorowski A, Ramamoorthy A, Paris A, Moaddel R, Cloix JF, Wainer IW. Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouse. Pharmacology Research & Perspectives. 1: e00010. PMID 25505565 DOI: 10.1002/Prp2.10  0.67
2013 Paul RK, Wnorowski A, Gonzalez-Mariscal I, Moaddel R, Indig FE, Wainer IW, Bernier M. Abstract 5516: (R,R’)-4’-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells. Cancer Research. 73: 5516-5516. DOI: 10.1158/1538-7445.Am2013-5516  0.667
2013 Paul RK, Wnorowski A, Indig FE, Bernier M, Wainer IW. Abstract 1023: Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,R’)-4’-methoxy-1-naphthylfenoterol in rat C6 glioma cell line. Cancer Research. 73: 1023-1023. DOI: 10.1158/1538-7445.Am2013-1023  0.684
2011 Oldak M, Tolzmann L, Wnorowski A, Podgórska MJ, Silling S, Lin R, Hiscott J, Müller CS, Vogt T, Smola H, Smola S. Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7. Journal of Virology. 85: 178-88. PMID 20980500 DOI: 10.1128/Jvi.00998-10  0.701
2010 Ołdak M, Kowalewski C, Maksym RB, Woźniak K, Pollak A, Podgórska M, Wnorowski A, Kosińska J, Płoski R. Novel keratin 14 hotspot mutation in Dowling-Meara type of epidermolysis bullosa simplex: strategy to avoid KRT14 pseudogene amplification by a simple approach. Journal of Dermatological Science. 57: 69-70. PMID 19854623 DOI: 10.1016/J.Jdermsci.2009.09.006  0.567
Show low-probability matches.